This site requires JavaScript to be enabled. Please enable JavaScript in your browser settings, or upgrade to a modern browser.

[TOP STORY] Have you been putting healthcare into your offshore portfolios?

Loading player...

New investors might opt for Pfizer, with its somewhat better metrics and yield, as well as its access to the mRNA technology, says Gary Booysen from Rand Swiss.

23 Jul 2021 4AM English South Africa Business News · Business

Other recent episodes

[TOP STORY] Preparing SA’s infrastructure and economy for an ageing population

Barry Kaganson, CEO of Auria Senior Living, points to the worrying projection that ‘about one in six South Africans will be over the age of 60 by 2050’ – many requiring mental, physical and financial assistance.

15 Oct 2AM 6 min

China stocks: Too cheap to ignore?

A look at China’s stock market struggles as US markets reach new highs, and why South Africa is ill-prepared for its ageing population.

15 Oct 1AM 21 min

[TOP STORY] Overhauling trust administration

Citadel Fiduciary partner Mbonisi Ndlovu reviews the impacts of the proposed Regulation of Trusts Bill 2026.

14 Oct 2AM 7 min

Bytes Technology sells off on strong results

A look at the sharp sell-off in Bytes Technology shares following its results and acquisition of CyberOne, and whether South Africa’s auditing profession is ready for the future.

14 Oct 1AM 23 min

[TOP STORY] The positive bond feedback loop: SA’s economic resilience

Izak Odendaal of Old Mutual Wealth looks at why global bond turmoil is putting local bonds in focus ahead of the MTBPS.

13 Oct 2AM 5 min

All episodes